Generics and biosimilars could emerge after 2026, with legal battles and manufacturing challenges potentially delaying availability
Given the heterogeneity of AUD and the complexity of the effect of alcohol on neural and physiological systems, there is a critical need to explore alternative pharmacotherapies that act through novel mechanisms
GLP-1s sneak in to areas that control your food intake, says Randy Seeley, PhD, director of the Michigan Nutrition Obesity Research Center at the University of Michigan
Start Your Medical Weight Loss Journey Weight loss is not one-size-fits-all
But dose reduction is a legitimate strategy in several situations
According to the study, Body weight and body composition were maintained one year after termination of supervised exercise, in contrast to weight regain after termination of treatment with obesity pharmacotherapy alone. Dr Winnett says the bottom line is to just get moving